The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Nanomedicine in cancer therapy: Innovative trends and prospects
Open accessAbstract
Cancer is a leading cause of morbidity and mortality worldwide, with recent advancements resulting in modest impacts on patient survival. Nanomedicine represents an innovative field with immense potential for improving cancer treatment, having ushered in several established drug delivery platforms. Nanoconstructs such as liposomes are widely used in clinics, while polymer micelles are in advanced phases of clinical trials in several countries. Currently, the field of nanomedicine is generating a new wave of nanoscale drug delivery strategies, embracing trends that involve the functionalization of these constructs with moieties that enhance site‐specific delivery and tailored release. Herein, we discuss several advancements in established nanoparticle technologies such as liposomes, polymer micelles, and dendrimers regarding tumor targeting and controlled release strategies, which are being incorporated into their design with the hope of generating a more robust and efficacious nanotherapeutic modality. We also highlight a novel strategy known as multistage drug delivery; a rationally designed nanocarrier aimed at overcoming numerous biological barriers involved in drug delivery through the decoupling of various tasks that comprise the journey from the moment of systemic administration to arrival at the tumor site. (Cancer Sci 2011; 102: 1247–1252)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Healing sound: the use of ultrasound in drug delivery and other therapeutic applications
Mitragotri, S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1662 · Cited by 980
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Self-citationRoss, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
European Organization for Research and Treatment of Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/ykqg4k · Cited by 756
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
Olson, R. D., & Mushlin, P. S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210154 · Cited by 690
Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A. D., Price, B. K., Cheng, M. M.-C., Decuzzi, P., Tour, J. M., Robertson, F., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.34 · Cited by 668
Self-citationDendrimers as versatile platform in drug delivery applications
Svenson, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.023 · Cited by 570
Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., Rha, S. Y., Lee, M. Y., & Ro, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9591-y · Cited by 541
Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
Peer, D., Park, E. J., Morishita, Y., Carman, C. V., & Shimaoka, M. (2008) · Science · doi:10.1126/science.1149859 · Cited by 493
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460800 · Cited by 434
Lasic, D. D., & Papahadjopoulos, D. (1995) · Science · doi:10.1126/science.7871422 · Cited by 432
Ananta, J. S., Godin, B., Sethi, R., Moriggi, L., Liu, X., Serda, R. E., Krishnamurthy, R., Muthupillai, R., Bolskar, R. D., Helm, L., et al. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.203 · Cited by 409
Self-citationMultifunctional Micellar Nanomedicine for Cancer Therapy
Blanco, E., Kessinger, C. W., Sumer, B. D., & Gao, J. (2009) · Experimental Biology and Medicine · doi:10.3181/0808-mr-250 · Cited by 332
Self-citationSingh, P., Gupta, U., Asthana, A., & Jain, N. K. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800125u · Cited by 329
Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles
Tanaka, T., Mangala, L. S., Vivas-Mejia, P. E., Nieves-Alicea, R., Mann, A. P., Mora, E., Han, H.-D., Shahzad, M. M. K., Liu, X., Bhavane, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3931 · Cited by 316
Self-citationUltrasound triggered release of cisplatin from liposomes in murine tumors
Schroeder, A., Honen, R., Turjeman, K., Gabizon, A., Kost, J., & Barenholz, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.007 · Cited by 305
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin
Talelli, M., Iman, M., Varkouhi, A. K., Rijcken, C. J. F., Schiffelers, R. M., Etrych, T., Ulbrich, K., van Nostrum, C. F., Lammers, T., Storm, G., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.005 · Cited by 267
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
Self-citationPegram, M. D., Konecny, G., & Slamon, D. J. (2000) · Cancer Treatment and Research · doi:10.1007/978-1-4757-3147-7_4 · Cited by 222
Ferrari, M. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.46 · Cited by 217
Self-citationNorthfelt, D. W., Dezube, B. J., Thommes, J. A., Levine, R., Von Roenn, J. H., Dosik, G. M., Rios, A., Krown, S. E., DuMond, C., & Mamelok, R. D. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.653 · Cited by 170
Tailored Porous Silicon Microparticles: Fabrication and Properties
Chiappini, C., Tasciotti, E., Fakhoury, J. R., Fine, D., Pullan, L., Wang, Y., Fu, L., Liu, X., & Ferrari, M. (2010) · ChemPhysChem · doi:10.1002/cphc.200900914 · Cited by 170
Self-citationDesign maps for nanoparticles targeting the diseased microvasculature
Decuzzi, P., & Ferrari, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.025 · Cited by 168
Self-citationKono, K., Ozawa, T., Yoshida, T., Ozaki, F., Ishizaka, Y., Maruyama, K., Kojima, C., Harada, A., & Aoshima, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.045 · Cited by 167
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation
Godin, B., Gu, J., Serda, R. E., Bhavane, R., Tasciotti, E., Chiappini, C., Liu, X., Tanaka, T., Decuzzi, P., & Ferrari, M. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32807 · Cited by 166
Self-citationThe association of silicon microparticles with endothelial cells in drug delivery to the vasculature
Serda, R. E., Gu, J., Bhavane, R. C., Liu, X., Chiappini, C., Decuzzi, P., & Ferrari, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.019 · Cited by 163
Self-citationPolymeric Micellar Delivery Systems in Oncology
Matsumura, Y. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn116 · Cited by 135
Development of a highly stable and targetable nanoliposomal formulation of topotecan
Drummond, D. C., Noble, C. O., Guo, Z., Hayes, M. E., Connolly-Ingram, C., Gabriel, B. S., Hann, B. C., Liu, B., Park, J. W., & Hong, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.006 · Cited by 115
Hamilton, A. L., Biganzoli, L., Coleman, R. E., Mauriac, L., Hennebert, P., Awada, A. H., Nooij, M., Beex, L. V. A. M., Piccart, M. J., Hoorebeeck, I. V., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf157 · Cited by 105
Khemtong, C., Kessinger, C. W., Ren, J., Bey, E. A., Yang, S.-G., Guthi, J. S., Boothman, D. A., Sherry, A. D., & Gao, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3231 · Cited by 104
Dritschilo, A., Huang, C. H., Rudin, C. M., Marshall, J. L., Collins, B., Dul, J. L., Zhang, C., Kumar, D., Gokhale, P. C., Ahmad, A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1260 · Cited by 91
Yao, H., Veine, D. M., Fay, K. S., Staszewski, E. D., Zeng, Z.-Z., & Livant, D. L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0826-y · Cited by 29
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 565
Cancer nanomedicines: So many papers and so few drugs!
Venditto, V. J., & Szoka, F. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 537
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.025 · Cited by 406
Metadata
- Authors
- Blanco, E., Hsiao, A., Mann, A. P., Landry, M. G., Meric‐Bernstam, F., & Ferrari, M.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2011-05-03
- Volume
- 102
- Issue
- 7
- Pages
- 1247-1252
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W1979716619
- Cited by
- 265
- References
- 46
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.